HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $20.00M; Long-term Debt, Excluding Current MaturitiesUSD $133.96M; Long-term DebtUSD $153.96M; Long-Term Debt, Maturity, Year OneUSD $20.00M.
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $20.00M; Long-term Debt, Excluding Current MaturitiesUSD $138.81M; Long-term DebtUSD $158.81M; Long-Term Debt, Maturity, Year OneUSD $20.00M.
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $20.00M; Long-term Debt, Excluding Current MaturitiesUSD $143.66M; Long-term DebtUSD $163.66M; Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD $20.00M.
HARMONY BIOSCIENCES HOLDINGS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Long-term Debt, Gross USD | Long-Term Debt, Maturity, Year Five USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $20.00M | $133.96M | $153.96M | $20.00M | $125.00M | (m) | (m) | $10.00M | $155.00M | (m) |
| 2026-03-31 | $20.00M | $138.81M | $158.81M | $20.00M | $125.00M | (m) | (m) | $15.00M | $160.00M | (m) |
| 2025-12-31 | $20.00M | $143.66M | $163.66M | (m) | (m) | (m) | (m) | (m) | $165.00M | (m) |
| 2025-12-31 | (m) | (m) | (m) | $20.00M | $20.00M | $125.00M | (m) | (m) | (m) | (m) |
| 2025-09-30 | $20.00M | $148.51M | $168.51M | $20.00M | $20.00M | $125.00M | (m) | $5.00M | $170.00M | (m) |
| 2025-06-30 | $18.75M | $153.34M | $172.09M | $20.00M | $20.00M | $125.00M | (m) | $8.75M | $173.75M | (m) |
| 2025-03-31 | $17.50M | $158.18M | $175.68M | $20.00M | $20.00M | $125.00M | (m) | $12.50M | $177.50M | (m) |
| 2024-12-31 | $16.25M | $163.02M | $179.27M | (m) | (m) | (m) | (m) | (m) | $181.25M | (m) |
| 2024-12-31 | (m) | (m) | (m) | $16.25M | $20.00M | $20.00M | $125.00M | (m) | (m) | (m) |
| 2024-09-30 | $15.00M | $167.85M | $182.85M | $16.25M | $20.00M | $20.00M | $125.00M | $3.75M | $185.00M | (m) |
| 2024-06-30 | $15.00M | $171.42M | $186.42M | $16.25M | $20.00M | $20.00M | $125.00M | $7.50M | $188.75M | (m) |
| 2024-03-31 | $15.00M | $175.00M | $190.00M | $16.25M | $20.00M | $20.00M | $125.00M | $11.25M | $192.50M | (m) |
| 2023-12-31 | $15.00M | $178.57M | $193.57M | (m) | (m) | (m) | (m) | (m) | $196.25M | (m) |
| 2023-12-31 | (m) | (m) | (m) | $15.00M | $16.25M | $20.00M | $20.00M | (m) | (m) | $125.00M |
| 2023-09-30 | $15.00M | $182.13M | $197.13M | $15.00M | $16.25M | $20.00M | $20.00M | $3.75M | $200.00M | (m) |
| 2023-06-30 | $11.00M | $180.49M | $191.49M | $20.00M | $20.00M | $155.50M | (m) | $1.00M | $196.50M | (m) |
| 2023-03-31 | $6.50M | $185.06M | $191.56M | $20.00M | $20.00M | $155.50M | (m) | $1.50M | $197.00M | (m) |
| 2022-12-31 | $2.00M | $189.65M | $191.65M | (m) | (m) | (m) | (m) | (m) | $197.50M | (m) |
| 2022-12-31 | (m) | (m) | (m) | $2.00M | $20.00M | $20.00M | $155.50M | (m) | (m) | (m) |
| 2022-09-30 | $2.00M | $189.72M | $191.72M | $2.00M | $20.00M | $20.00M | $155.50M | $500.00K | $198.00M | (m) |
| 2022-06-30 | $2.00M | $189.81M | $191.81M | $2.00M | $20.00M | $20.00M | $155.50M | $1.00M | $198.50M | (m) |
| 2022-03-31 | $2.00M | $189.90M | $191.90M | $2.00M | $20.00M | $20.00M | $155.50M | $1.50M | $199.00M | (m) |
| 2021-12-31 | $2.00M | $189.98M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | $191.98M | (m) | (m) | (m) | (m) | (m) | $199.50M | (m) |
| 2021-12-31 | (m) | (m) | (m) | $2.00M | $2.00M | $20.00M | $20.00M | (m) | (m) | $155.50M |
| 2021-09-30 | $2.00M | $190.07M | $192.07M | $2.00M | $2.00M | $20.00M | $20.00M | $500.00K | $200.00M | (m) |
| 2021-06-30 | (m) | $195.61M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $194.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $194.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | $194.25M | (m) | (m) | (m) | (m) | (m) | $200.00M | (m) |
| 2020-09-30 | (m) | $192.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $97.95M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |